BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2527721)

  • 21. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed-type sensitivity reaction to mitomycin.
    Giorgini S; Martinelli C; Sertoli A
    Contact Dermatitis; 1991 May; 24(5):378-9. PubMed ID: 1832622
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed-type hypersensitivity reaction to ethambutol and isoniazid.
    Bakkum RS; Waard-Van Der Spek FB; Thio HB
    Contact Dermatitis; 2002 Jun; 46(6):359. PubMed ID: 12190628
    [No Abstract]   [Full Text] [Related]  

  • 24. Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy.
    Klein GF; Kofler H; Wolf H; Fritsch PO
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):703-7. PubMed ID: 2530252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed hypersensitivity drug reactions diagnosed by patch testing.
    Calkin JM; Maibach HI
    Contact Dermatitis; 1993 Nov; 29(5):223-33. PubMed ID: 8112060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed-type hypersensitivity to bupivacaine.
    Nettis E; Colanardi MC; Calogiuri GF; Foti C; Priore MG; Ferrannini A; Vacca A
    Allergy; 2007 Nov; 62(11):1345-6. PubMed ID: 17822450
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed reaction to oral treatment with clindamycin.
    Vicente J; Fontela JL
    Contact Dermatitis; 1999 Oct; 41(4):221. PubMed ID: 10515103
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparins and skin reactions: from diagnostic to management].
    Barouti N; Masouyé I; Boehncke WH; Prins C
    Rev Med Suisse; 2013 Apr; 9(380):705-6, 708-11. PubMed ID: 23621039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous reaction to low-molecular-weight heparin.
    Sivakumaran M; Ghosh K
    Br J Haematol; 2002 May; 117(2):257. PubMed ID: 11972505
    [No Abstract]   [Full Text] [Related]  

  • 31. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics.
    Romano A; Di Fonso M; Pietrantonio F; Pocobelli D; Giannarini L; Del Bono A; Fabrizi G; Venuti A
    Contact Dermatitis; 1993 Mar; 28(3):190. PubMed ID: 8462302
    [No Abstract]   [Full Text] [Related]  

  • 32. Skin lesions, hypereosinophilia, and subcutaneous heparin.
    Bircher AJ; Itin PH; Büchner SA
    Lancet; 1994 Apr; 343(8901):861. PubMed ID: 7908111
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
    Boehncke WH; Weber L; Gall H
    Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed hypersensitivity to scopolamine delivered by a transdermal device.
    Trozak DJ
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):247-51. PubMed ID: 2931457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rash from oral codeine.
    van Ketel WG
    Contact Dermatitis; 1986 Sep; 15(3):195. PubMed ID: 2946544
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of cutaneous type IV hypersensitivity reactions induced by heparin.
    Ludwig RJ; Schindewolf M; Utikal J; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2006 Nov; 96(5):611-7. PubMed ID: 17080218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
    Salava A; Alanko K; Hyry H
    Contact Dermatitis; 2012 Aug; 67(2):103-4. PubMed ID: 22775544
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone.
    Nucera E; Buonomo A; Pollastrini E; De Pasquale T; Del Ninno M; Roncallo C; Schiavino D; Patriarca G
    Dermatology; 2002; 204(3):248-50. PubMed ID: 12037457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic allergic dermatitis resulting from oral administration of chromium with a food supplement.
    De Marchi S; Cecchin E; De Marchi SU
    Contact Dermatitis; 2014 Feb; 70(2):123-5. PubMed ID: 24450828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.